These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19998192)

  • 21. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomization can be risky.
    Lott J
    Am J Bioeth; 2009 Feb; 9(2):17-8. PubMed ID: 19180386
    [No Abstract]   [Full Text] [Related]  

  • 23. Understanding randomization: helpful strategies.
    Brody H; Childress AM
    Am J Bioeth; 2009 Feb; 9(2):14-5. PubMed ID: 19180384
    [No Abstract]   [Full Text] [Related]  

  • 24. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dirty little truth: we want them to understand, but not really..
    Morreim H
    Am J Bioeth; 2009 Feb; 9(2):9-11. PubMed ID: 19180381
    [No Abstract]   [Full Text] [Related]  

  • 26. Equipoise trumps randomization.
    Fox MD; Hellman CM; Jelley MR
    Am J Bioeth; 2009 Feb; 9(2):13-4. PubMed ID: 19180383
    [No Abstract]   [Full Text] [Related]  

  • 27. The rationale for placebo-controlled trials: methodology and policy considerations.
    Miller FG
    Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193
    [No Abstract]   [Full Text] [Related]  

  • 28. Obligations in offering to disclose genetic research results.
    Fernandez CV; Weijer C
    Am J Bioeth; 2006; 6(6):44-6; author reply W10-2. PubMed ID: 17085409
    [No Abstract]   [Full Text] [Related]  

  • 29. A duty to deceive: placebos in clinical practice.
    Foddy B
    Am J Bioeth; 2009 Dec; 9(12):4-12. PubMed ID: 20013484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vulnerability as the inability of researchers to act in the best interest of a subject.
    VanderWalde AM
    Am J Bioeth; 2004; 4(3):65-6; discussion W32. PubMed ID: 16192147
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomization and the transactional framework for informed consent.
    Reynolds D; Fleming DA
    Am J Bioeth; 2009 Feb; 9(2):16-7. PubMed ID: 19180385
    [No Abstract]   [Full Text] [Related]  

  • 32. Must research participants understand randomization?
    Wendler D
    Am J Bioeth; 2009 Feb; 9(2):3-8. PubMed ID: 19180378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing dilemmas in the ethics of placebo-controlled trials.
    Kovach K
    Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072
    [No Abstract]   [Full Text] [Related]  

  • 34. Equipoise may be in the eye of the beholder.
    Moyer A; Floyd AH
    Am J Bioeth; 2009 Feb; 9(2):21-2. PubMed ID: 19180388
    [No Abstract]   [Full Text] [Related]  

  • 35. Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception.
    Appelbaum PS
    Am J Bioeth; 2002; 2(2):22-3. PubMed ID: 12189066
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical considerations in the communication of unexpected information with clinical implications.
    Lavieri RR; Garner SA
    Am J Bioeth; 2006; 6(6):46-8; author reply W10-2. PubMed ID: 17085410
    [No Abstract]   [Full Text] [Related]  

  • 37. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doctor vs. scientist?
    Jansen LA
    Hastings Cent Rep; 2008; 38(2):3. PubMed ID: 18457215
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical research should not be permitted to escape the ethical orbit of clinical care.
    Steinberg D
    Am J Bioeth; 2002; 2(2):27-8. PubMed ID: 12189069
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms involved in placebo and nocebo responses and implications for drug trials.
    Rief W; Bingel U; Schedlowski M; Enck P
    Clin Pharmacol Ther; 2011 Nov; 90(5):722-6. PubMed ID: 21975346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.